abs297.txt	stromal	cells	within	the	tumor	microenvironment	play	a	supportive	role	in	tumorgrowth		progression	and	treatment	resistance	therefore	these	nonmalignantcells	are	potential	therapeutic	targets	this	issue	of	jci	szot	et	al	devised	strategy	to	exploit	cell-surface	marker	tem8	(also	known	asantxr1)	which	is	expressed	by	cancer-associated	as	zip	code	todeliver	an	antibody-drug	conjugate	(adc)	linked	potent	cancer-killing	drugmonomethyl	auristatin	e	(mmae)	preclinical	experimental	metastasismodels	multiple	cancer	types	tem8-adc	targeted	tem8-expressingcancer-associated	processed	liberated	membrane-permeablemmae	released	drug	via	p-glycoprotein	(p-gp)	transporter	mmae	killed	through	bystander	mechanism	that	did	minimaldamage	themselves	p-gp-expressing	displayedmmae	suggesting	p-gp	expression	status	may	identify	patients	whomight	benefit	most	from	termed	daarts	(drugactivation	release	stroma)	represents	elegant	example	howselective	molecule	on	stroma	canbe	exploited	facilitate	delivery	shrink	solid	tumors
